Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

This study has been completed.
Quintiles, Inc.
Aptuit Inc.
Cenduit LLC
PHT Corporation
Information provided by (Responsible Party):
Stallergenes Identifier:
First received: November 15, 2012
Last updated: November 22, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)